Rhumbline Advisers increased its position in shares of DENTSPLY SIRONA Inc (NASDAQ:XRAY) by 1.7% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 482,149 shares of the medical instruments supplier’s stock after buying an additional 8,193 shares during the quarter. Rhumbline Advisers’ holdings in DENTSPLY SIRONA were worth $31,740,000 as of its most recent SEC filing.
Several other large investors have also recently bought and sold shares of the stock. NuWave Investment Management LLC bought a new position in DENTSPLY SIRONA in the fourth quarter valued at approximately $121,000. Massey Quick Simon & CO. LLC bought a new position in DENTSPLY SIRONA in the third quarter valued at approximately $124,000. Huntington National Bank bought a new position in DENTSPLY SIRONA in the third quarter valued at approximately $157,000. First Interstate Bank bought a new position in DENTSPLY SIRONA in the third quarter valued at approximately $164,000. Finally, Stock Yards Bank & Trust Co. bought a new position in DENTSPLY SIRONA in the fourth quarter valued at approximately $203,000. Institutional investors and hedge funds own 96.05% of the company’s stock.
DENTSPLY SIRONA Inc (NASDAQ XRAY) opened at $58.15 on Wednesday. The company has a debt-to-equity ratio of 0.21, a quick ratio of 1.59 and a current ratio of 2.32. DENTSPLY SIRONA Inc has a one year low of $52.53 and a one year high of $68.98. The company has a market capitalization of $13,360.00, a P/E ratio of -16.71, a PEG ratio of 2.16 and a beta of 1.17.
The firm also recently announced a quarterly dividend, which will be paid on Friday, April 13th. Stockholders of record on Thursday, March 29th will be paid a dividend of $0.0875 per share. The ex-dividend date of this dividend is Wednesday, March 28th. This represents a $0.35 annualized dividend and a dividend yield of 0.60%. DENTSPLY SIRONA’s dividend payout ratio is currently -10.06%.
In other news, Director Eric Brandt sold 6,409 shares of DENTSPLY SIRONA stock in a transaction that occurred on Monday, January 8th. The stock was sold at an average price of $68.04, for a total transaction of $436,068.36. Following the completion of the transaction, the director now directly owns 12,073 shares in the company, valued at approximately $821,446.92. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 1.99% of the company’s stock.
A number of research firms have weighed in on XRAY. HC Wainwright downgraded DENTSPLY SIRONA from a “buy” rating to a “neutral” rating and set a $68.00 price target for the company. in a research note on Thursday, November 30th. Zacks Investment Research downgraded DENTSPLY SIRONA from a “hold” rating to a “sell” rating in a research note on Monday, January 8th. Stephens began coverage on DENTSPLY SIRONA in a research note on Tuesday, November 28th. They issued an “overweight” rating and a $75.00 price target for the company. Credit Suisse Group downgraded DENTSPLY SIRONA to a “hold” rating and set a $73.00 price target for the company. in a research note on Friday, January 5th. Finally, BidaskClub downgraded DENTSPLY SIRONA from a “strong-buy” rating to a “buy” rating in a research note on Saturday, December 2nd. Three investment analysts have rated the stock with a sell rating, four have given a hold rating and eight have given a buy rating to the stock. The stock presently has an average rating of “Hold” and an average target price of $69.15.
WARNING: “Rhumbline Advisers Boosts Position in DENTSPLY SIRONA Inc (XRAY)” was originally reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are reading this article on another website, it was illegally stolen and reposted in violation of United States & international copyright & trademark law. The correct version of this article can be read at https://www.dispatchtribunal.com/2018/02/21/rhumbline-advisers-boosts-position-in-dentsply-sirona-inc-xray.html.
DENTSPLY SIRONA Company Profile
DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.
Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc (NASDAQ:XRAY).
Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.